Global Nuclear Medicine Market: Analysis By Product Type ... · 7.4 Global Brachytherapy Nuclear...

Global Nuclear Medicine Market: Analysis By Product Type

(Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By

Therapeutic Nuclear Medicine Type, By Indication, By Region, By

Country (2019 Edition): Opportunities and Forecast (2013-2023)

• By Diagnostic Nuclear Medicine Type - SPECT, PET

• By Therapeutics Nuclear Medicine Type - Alpha

Emitters, Beta Emitters, Brachytherapy

• By Indication - Cardiovascular Disorders, Neurological

disorders, Oncological disorders, Others

• By Region- North America, Europe, APAC and ROW

• By Country – U.S, Canada, U.K, Germany, Japan,

China, India, Brazil

January 2019

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Glo

bal

Market (By Value)

By Product, By Value

Diagnostic

Therapeutic

By Diagnostic Nuclear Medicine,

By Value

SPECT

PET

By Therapeutics Nuclear Medicine,

By Value

Alpha Emitters

Beta Emitters

Brachytherapy

By Indications, By Value

Cardiovascular Disorders

Neurological Disorders

Oncological Disorders

Others

Historical Forecast

Scope of the Report – Nuclear Medicine Market

2

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Reg

ion

al

Market (By Value)

By Product, By Value

Diagnostic

Therapeutic

By Diagnostic Nuclear Medicine,

By Value

SPECT

PET

By Therapeutics Nuclear Medicine,

By Value

Alpha Emitters

Beta Emitters

Brachytherapy

By Indications, By Value




Others

Historical Forecast


3

C

ou

ntr

y

By Indication, By Value




Others

Company Analysis Curium, Advanced Accelerator Applications, Jubilant Life Sciences, Cardinal Health, 3B Pharmaceutical Bracco Imaging, Eckert & Ziegler ,Lantheus Holding

Regional Analysis North America, Europe, APAC and ROW

Country Analysis U.S, Canada, Germany, France, China, India, Japan and Brazil

Historical Forecast


4

Table of Content

S.No Particulars Page No.

1. Research Methodology 24

2. Executive Summary 25

3. Strategic Recommendation 26

3.1 Focus on Technological Advancements

27

3.2 APAC region to witness augmented growth in the forecast period.

28

4. Nuclear Medicine Market Overview 30

5. Global Nuclear Medicine : Growth and Forecast 37

5.1 By Value (2013-2017) 38

5.2 By Value (2018-2023) 39

6. Global Nuclear Medicine Market: By Indication 45

6.1 Global Nuclear Medicine Market-By Product Type: Breakdown(%) 52

6.1.1 Global Nuclear Medicine Market Size and Share, By Product Type, 2017 53

6.1.2 Global Nuclear Medicine Market Size and Share, By Product Type, 2023 54

6.2 Global Diagnostic Nuclear Medicine Market Overview 55

6.2.1 By Value (2013-2023) 55

5

Table of Content

S. No Particulars Page No.

6.3 Global Therapeutic Nuclear Medicine Market Overview 58

6.3.1 By Value (2013-2023) 58

7 Global Nuclear Medicine Market: By Therapeutic Type 62

7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%) 63

7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017 63

7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023 63

7.2 Global Beta Emitters Nuclear Medicine Market Overview 65

7.2.1 By Value (2013-2023) 65

7.3 Global Alpha Emitters Nuclear Medicine Market Overview 66

7.3.1 By Value (2013-2023) 66

7.4 Global Brachytherapy Nuclear Medicine Market Overview 68

7.4.1 By Value (2013-2023)

68

6

Table of Content


8 Global Nuclear Medicine Market :By Diagnostic Type 69

8.1 Global Nuclear Medicine Market :By Diagnostic Type: Breakdown(%) 70

8.1.1 Global Nuclear Medicine Market :By Diagnostic Type, 2017 70

8.1.2 Global Nuclear Medicine Market :By Diagnostic Type, 2023 71

8.2 Global SPECT Nuclear Medicine Market Overview 72

8.2.1 By Value (2013-2023) 73

8.3 Global PET Nuclear Medicine Market Overview 75

8.3.1 By Value (2013-2023) 76

9 Global Nuclear Medicine Market :By Indication 78

9.1 Global Nuclear Medicine Market :By Indication: Breakdown(%) 79

9.1.1 Global Nuclear Medicine Market :Indication, 2017 79

9.1.2 Global Nuclear Medicine Market :Indication, 2023 80

7

Table of Content


9.2 Global Nuclear Medicine For Oncological Disorders Market 81

9.2.1 By Value (2013-2023) 81

9.3 Global Nuclear Medicine For Cardiovascular Disorders Market 84

9.3.1 By Value (2013-2023) 84

9.4 Global Nuclear Medicine For Neurological Disorders Market

86

9.4.1 By Value (2013-2023) 86

9.5 Global Nuclear Medicine For Other Disorders Market

87

9.5.1 By Value (2013-2023) 87

10. Global Nuclear Medicine Market: Regional Analysis 88

10.1 Global Nuclear Medicine Market, By Region: Breakdown (%) 89

10.1.1 Global Nuclear Medicine Market Size, By Region, 2017 (%) 89

10.1.2 Global Nuclear Medicine Market Size, By Region, 2023 (%) 90

8

Table of Content


10.2 North America Nuclear Medicine Market: An Analysis 91

10.2.1 By Value (2013-2017) 92

10.2.2 By Value (2018-2023) 94

10.3 North America Nuclear Medicine Market: Segment Analysis 95

10.3.1 North America Nuclear Medicine Market: By Product Type , By Value(2013-2023) 96

10.3.2 North America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 97

10.3.3 North America Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 98

10.3.4 North America Nuclear Medicine Market: By Indication, By Value (2013-2023) 99

10.4 North America Nuclear Medicine Market: Country Analysis (U.S. and Canada) 105

10.4.1 U.S. Nuclear Medicine Market, By Value (2013-2023) 106

10.4.1.1 U.S. Nuclear Medicine Market, By Indication, By Value (2013-2023) 108

9

Table of Content


10.4.2 Canada Nuclear Medicine Market, By Value (2013-2023) 113

10.4.2.1 Canada Nuclear Medicine Market, By Indication, By Value (2013-2023) 114

10.5 Europe Nuclear Medicine Market: An Analysis 118

10.5.1 By Value (2013-2017) 119

10.5.2 By Value (2018-2023) 120

10.6 Europe Nuclear Medicine Market: Segment Analysis 123

10.6.1 Europe Nuclear Medicine Market: By Product Type , By Value(2013-2023) 124

10.6.2 Europe America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 125

10.6.3 Europe Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 126

10.6.4 Europe Nuclear Medicine Market: By Indication, By Value (2013-2023) 127

10.7 Europe Nuclear Medicine Market: Country Analysis (Germany, France., Rest of Europe) 131

10.7.1 Germany Nuclear Medicine Market, By Value (2013-2023) 134

10.7.1.1 Germany Nuclear Medicine Market, By Indication, By Value (2013-2023) 135

10.7.2 France Nuclear Medicine Market, By Value (2013-2023) 140

10.7.2.1 France Nuclear Medicine Market, By Indication, By Value (2013-2023) 141

10

Table of Content


10.7.3 Rest of Europe Nuclear Medicine Market, By Value (2013-2023) 146

10.8 Asia Pacific Nuclear Medicine Market: An Analysis 147

10.8.1 By Value (2013-2017) 148

10.8.2 By Value (2018-2023) 149

10.9 Asia Pacific Nuclear Medicine Market: Segment Analysis 150

10.9.1 Asia Pacific Nuclear Medicine Market: By Product Type , By Value(2013-2023) 151

10.9.2 Asia Pacific America Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 152

10.9.3 Asia Pacific Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 153

10.9.4 Asia Pacific Nuclear Medicine Market: By Indication, By Value (2013-2023) 154

10.10 Asia Pacific Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of Asia Pacific) 157

10.10.1 China Nuclear Medicine Market, By Value (2013-2023) 160

10.10.1.1 China Nuclear Medicine Market, By Indication, By Value (2013-2023) 163

10.10.2 Japan Nuclear Medicine Market, By Value (2013-2023) 168

10.10.2.1 Japan Nuclear Medicine Market, By Indication, By Value (2013-2023) 170

10.10.3 India Nuclear Medicine Market, By Value (2013-2023) 175

10.10.3.1 India Nuclear Medicine Market, By Indication, By Value (2013-2023) 177

10.10.4 Rest of Asia Pacific Nuclear Medicine Market, By Value (2013-2023) 180

11

Table of Content


10.11 Rest of World Nuclear Medicine Market: An Analysis 181

10.11.1 By Value (2013-2017) 182

10.11.2 By Value (2018-2023) 183

10.12 Rest of World Nuclear Medicine Market: Segment Analysis 184

10.12.1 Rest of World Nuclear Medicine Market: By Product Type , By Value(2013-2023) 185

10.12.2 Rest of World Nuclear Medicine Market: By Diagnostic Type , By value (2013-2023) 186

10.12.3 Rest of World Nuclear Medicine Market: By Therapeutic Type , By value (2013-2023) 187

10.12.4 Rest of World Nuclear Medicine Market: By Indication, By Value (2013-2023) 188

10.13 Rest of World Nuclear Medicine Market: Country Analysis (Brazil & Others) 192

10.13.1 Brazil Nuclear Medicine Market, By Value (2013-2023) 195

10.13.1 Brazil Nuclear Medicine Market, By Indication, By Value (2013-2023) 196

10.13.2 Others Nuclear Medicine Market, By Value (2013-2023) 201

12

Table of Content


11. Market Dynamics 202

11.1 Drivers 203

11.2 Challenges 208

12. Market Trends 212

13. Porter’s Five Forces Analysis –Nuclear Medicine Market 213

14. SWOT Analysis –Nuclear Medicine Market 215

15. Supply Chain Analysis Nuclear Medicine Market 217

16. Policy and Regulatory Landscape 219

17. Competitive Landscape 227

18. Company Profiling 229

18.1 Eckert & Ziegler

230

18.2 Advanced Accelerator Applications 232

18.3 Cardinal Health 234

13

Table of Content


18.4 3B Pharmaceuticals 236

18.5 Jubilant Life Sciences 237

18.6 Curium 239

18.7 Lantheus Holdings 240

18.8 Bracco Imaging 242

14

List of Figures

Figure No. Figure Title Page No.

Figure 1: Nuclear Medicine Market Segmentation Flowchart 35

Figure 2: Nuclear Medicine Market Segmentation Flowchart 36

Figure 3: Global Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 38

Figure 4: Global Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million) 39

Figure 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total) 41

Figure 6: Projected global population aged 60 years & above In Billions) 41

Figure 7: Projected global population (In Billions) 41

Figure 8: Global Health Expenditure Per Capita, (2012-2016, USD Trillion) 42

Figure 9: Global Health Expenditure Per Capita, By Select Countries,(2016, USD) 42

Figure 10: Global Nuclear Medicine Market Size, By Product Type, 2017 (%) 53

Figure 11: Global Nuclear Medicine Market Size, By Product Type, 2023F (%) 54

Figure 12: Global Diagnostic Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 55

Figure 13: Global Diagnostic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 55

Figure 14: Global Therapeutic Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 58

Figure 15: Global Therapeutic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 58

Figure 16: Global Prevalence of Different Type of Cancer (2013-2017, Thousands) 60

Figure 17: Global Nuclear Medicine Market Size, By Therapeutic Type, 2017 (%) 63

Figure 18: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%) 64

Figure 19: Global Beta Emitters Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 65

Figure 20: Global Beta Emitters Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 65

15

List of Figures Figure No. Figure Title Page No.

Figure 21: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 66

Figure 22: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 66

Figure 23: Global Brachytherapy Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 68

Figure 24: Global Brachytherapy Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 68

Figure 25: Global Nuclear Medicine Market Size, By Diagnostic Type, 2017 (%) 70

Figure 26: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%) 71

Figure 27: Global SPECT Nuclear Medicine Market Size, By Value,2013-2017(USD Million) 73

Figure 28: Global SPECT Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million) 73

Figure 29: Global PET Nuclear Medicine Market Size, By Value, 2013-2017(USD Million) 76

Figure 30: Global PET Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 76

Figure 31: Global Nuclear Medicine Market Size, By Indication, 2017 (%) 79

Figure 32: Global Nuclear Medicine Market Size, By Indication, 2023 (%) 80

Figure 33: Global Nuclear Medicine For Oncological Disorders Market Size, By Value,2013-2017(USD Million) 81

Figure 34: Global Nuclear Medicine For Oncological Disorders Market Size, By Value,2018E-2023F (USD Million) 81

Figure 35: Prevalence of Cancer Per 100,000 in different Countries in 2018 ( In Thousands) 82

Figure 36: Global Prevalence of Different Type of Cancer in year 2016 & 2017 ( In Thousands) 83

Figure 37: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2013-2017(USD Million) 84

Figure 38: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million) 84

Figure 39: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million) 85

Figure 40: Global Prevalence of Cardiovascular Disease (2012-2016 , Million) 85

16

List of Figures


Figure 41: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2013-2017(USD Million) 86

Figure 42: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2018E-2023F (USD Million) 86

Figure 43: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million) 87

Figure 44: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million) 87

Figure 45: Global Nuclear Medicine Market Size, By Region, 2017 (%) 89

Figure 46: Global Nuclear Medicine Market Size, By Region, 2023F (%) 90

Figure 47: North America Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 92

Figure 48: North America Population above 65 year in Million (2015, 2030F, 2050F) 93

Figure 49: North America Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 94

Figure 50: North America Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 96

Figure 51: North America Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 97

Figure 52: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 98



Figure 55: Total Number of People With Cardiovascular Disorders in North America, By Type,2017 (In thousands) 101

Figure 56: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds) 102

Figure 57: North America Nuclear Medicine Market, Country Share, 2017 (% of Total) 104

Figure 58: North America Nuclear Medicine , Country Share, 2023F (% of Total) 104

Figure 59: United States Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 106

Figure 60: United States Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 106

17

List of Figures

Figure No. Figure Title

Page No.

Figure 61: U.S. Per Capita Health Expenditure, 2012-2016 ( USD) 107

Figure 62: United States Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 108

Figure 63: New Estimated Cases of Cancer in United States, By Type 2018 110

Figure 64: New Estimated Cases of Cancer in United States (2014-2018) 110

Figure 65: Estimated Cases of Cardiovascular Disorders in United States (2013-2017)(In Thousands) 110

Figure 66: United States Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 111

Figure 67: Total Number of People With Cardiovascular Disorders in United States, By Type,2017 (In thousands) 111

Figure 68: Total Number of People With Cardiovascular Disorders in United States, By Type,2017 (In thousands) 113

Figure 69: Canada Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 113

Figure 70: Canada Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 114

Figure 71: Canada Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 116

Figure 72: Total Number of People With Cardiovascular Disorders in Canada, By Type,2017 (In thousands) 116

Figure 73: Prevalence of Different Type of Cancer in Canada in year 2016 & 2017 ( In Hundreds) 117

Figure 74: Cancer Fact Sheet of Canada, 2017 117

Figure 75: Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 119

Figure 76: Europe Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 120

Figure 77: Number of Magnetic Resonance Imaging (MRI) Scans By Using Imaging Equipment Number, 2016, Per 100,000 Inhabitants

121

Figure 78: Europe Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 124

Figure 79: Europe Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 125

Figure 80: Europe Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 126

18

List of Figures


Figure 81: Europe Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 127

Figure 82: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Hundreds) 129

Figure 83: Western Europe Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 130

Figure 84: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2017 (In thousands) 130

Figure 85: Europe Nuclear Medicine Market, Country Share, 2017 (% of Total) 132

Figure 86: Europe Nuclear Medicine Market, Country Share, 2023 (% of Total) 132

Figure 87: Germany Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 134

Figure 88: Germany Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 134

Figure 89: Germany Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 135

Figure 90: Germany Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 137

Figure 91: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017 (In thousands) 137

Figure 92: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017 (In thousands) 138

Figure 93: France Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 140

Figure 94: France Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million) 140

Figure 95: France Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 141

Figure 96: France Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 143

Figure 97: Total Number of People With Cardiovascular Disorders in France, By Type,2017 (In thousands) 143

Figure 98: Prevalence of Different Type of Cancer in France in year 2016 & 2017 ( In Hundreds) 144

Figure 99: Rest of Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 146

Figure 100: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 146

19

List of Figures


Figure 101: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 148

Figure 102: Asia Pacific Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 149

Figure 103: Asia Pacific Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 151

Figure 104: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million) 152

Figure 105: Asia Pacific Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million) 153

Figure 106: Asia Pacific Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 154

Figure 107: Asia Pacific Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 156

Figure 108: Total Number of People With Cardiovascular Disorders in Asia Pacific, By Type,2017 156

Figure 109: Asia Pacific Nuclear Medicine Market, Country Share, 2017 (% of Total) 158

Figure 110: Asia Pacific Nuclear Medicine, Country Share, 2023 (% of Total) 158

Figure 111: China Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 160

Figure 112: China Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 160

Figure 113: China Healthcare Expenditure (2012-2016, USD Billion) 161

Figure 114: China Population 65 Years & Above (% of Total), 2012-2016 161

Figure 115: China Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 163

Figure 116: China Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 165

Figure 117: Total Number of People With Cardiovascular Disorders in China, By Type,2017 (In thousands) 165

Figure 118: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds) 166

Figure 119: Japan Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 168

Figure 120: Japan Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 168

20

List of Figures


Figure 121: Japan Per Capita Health Expenditure (2012-2016,USD) 169

Figure 122: Japan Population 65 Years & Above (% of Total), 2012-2016 169

Figure 123: Japan Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 170

Figure 124: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 172

Figure 125: Total Number of People With Cardiovascular Disorders in Japan, By Type,2017 (In thousands) 172

Figure 126: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds) 173

Figure 127: India Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million ) 175

Figure 128: India Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 175

Figure 129: India Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 177

Figure 130: Rest of Asia Pacific Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 180

Figure 131: Rest of Asia Pacific Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 180

Figure 132: Rest of World Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 182

Figure 133: Rest of World Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million ) 183

Figure 134: Rest of World Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million) 185



Figure 137: Rest of World Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 188

Figure 138: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 190

Figure 139: Total Number of People With Cardiovascular Disorders in North Africa and Middle East , By Type,2017 (In thousands)

190

Figure 140: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds) 191

21

List of Figures


Figure 141: Rest of World Nuclear Medicine Market, Country Share, 2017 (% of Total) 193

Figure 142: Rest of World Nuclear Medicine , Country Share, 2023 (% of Total) 193

Figure 143: Brazil Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 195

Figure 144: Brazil Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million 195

Figure 145: Brazil Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million) 196

Figure 146: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands) 198

Figure 147: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017 (In thousands) 198

Figure 148: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds) 199

Figure 149: Others Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million) 201

Figure 150: Others Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million) 201

Figure 151: Eckert &Ziegler Sales, 2013-2017 (USD Million) 231

Figure 152: Eckert &Ziegler Sales, By Business Group, 2017 (%) 231

Figure 153: Advanced Accelerator Applications Sales, 2014-2016 (USD Million) 233

Figure 154: Advanced Accelerator Applications Sales, By Business Group, 2017 (%) 233

Figure 155: Advanced Accelerator Applications Sales, By Region, 2017 (%) 233

Figure 156: Cardinal Health Sales, 2013-2017 (USD Billion) 235

Figure 157: Cardinal Health Sales, By Business Group, 2017 (%) 235

Figure 158: Cardinal Health Sales, By Region, 2017 (%) 235

Figure 159: Jubilant Life Sciences Sales, 2015FY-2018FY (USD Million) 238

Figure 160: Jubilant Life Sciences Sales, By Business Group, 2017 (%) 238

22

List of Figures


Figure 161: Jubilant Life Sciences Sales, By Region, 2017 (%) 238

Figure 162: Lantheus Holdings Revenue ,2016-2017 (USD Million) 241

Figure 163: Lantheus Holdings Revenue, By Product, 2017 (%) 241

Figure 164: Lantheus Holdings Revenue , By Region, 2017 (%) 241

Figure 165: Bracco Imaging Revenue , By Region, 2017 (%) 243

List of Table Table A: List of Abbreviations 29

Table B: Recent Company Acquisitions ,Mergers & Partnership in Nuclear Medicine Market 47

Table C: Pipeline of Diagnostic Nuclear Medicine 48

Table D: Pipeline of Diagnostic Nuclear Medicine 49

Table E: Pipeline of Diagnostic Nuclear Medicine 50

Table F: Pipeline of Diagnostic Nuclear Medicine 51

Table G: Radionuclide Used for Diagnosis and Treatment 57

Table H: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies 61

Table I: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies 228

23

For our study on Global Nuclear Medicine market, we have conducted comprehensive secondary research

followed by an extensive primary research. In the process of secondary research, we have scrutinized

industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters,

Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various

industry experts across the value chain of medical device industry.

Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the

industry in the last five years, and confirming the findings through primary research. Annual reports of the

companies were scanned to further validate the market size and to estimate the size of various other end-

user sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product

mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the

industry. All the relevant data points/ statistics in the forecast period are validated through relevant and

reliable primary sources.

Report Focus: Global Nuclear Medicine Market

- By Product(Diagnostic, Therapeutic)

- By Diagnostic (SPECT, PET)

- By Therapeutic ( Alpha emitters, Beta Emitters, Brachytherapy)

-By Indication(Oncology, Neurology, cardiology, Others)

-By Region (North America, Europe, Asia Pacific and Rest of the World),

- By Country ( U.S., Canada, France, Germany, India, China, Japan and Brazil).

Research Methodology

24

Global Nuclear Medicine Market Overview

Source: Azoth Analytics Estimates

Xx

Xx

Xx

Xx

Xx

Xx

Xx

xx

2013 2014 2015 2016 2017

Figure 3: Global Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)

CAGR 2013-2017

xx%

25

Global Nuclear Medicine Market Overview

xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

2018 2019 2020 2021 2022 2023


CAGR 2018-2023

xx%

Figure 4: Global Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million)

26


CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

Global Diagnostic Nuclear Medicine Market

Figure 12: Global Diagnostic Nuclear Medicine Market

Size, By Value,2013-2017(USD Million)

Figure 13: Global Diagnostic Nuclear Medicine Market

Size, By Value,2018E-2023F (USD Million)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

27


Global Therapeutic Nuclear Medicine Market

Figure 14: Global Therapeutic Nuclear Medicine Market

Size, By Value,2013-2017(USD Million)

Figure 15: Global Therapeutic Nuclear Medicine Market


28

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Global Nuclear Medicine Market- By Therapeutic Type

Figure 17: Global Nuclear Medicine Market Size, By

Therapeutic Type, 2017 (%)

xx

Alpha Emitters

Beta Emitters

Brachytherapy


Key Drivers

xx

xx

29

Global Nuclear Medicine Market- By Therapeutic Type

Figure 18: Global Nuclear Medicine Market Size, By Diagnostic

Type, 2023F (%)

xx


30

Alpha Emitters

Beta Emitters

Brachytherapy

Key Drivers

xx

xx


Global Beta Emitters Nuclear Medicine Market

Figure 19: Global Beta Emitters Nuclear Medicine

Market Size, By Value,2013-2017(USD Million)

Figure 20: Global Beta Emitters Nuclear Medicine Market


31

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

• .


Global Alpha Emitters Nuclear Medicine Market

Figure 21: Global Alpha Emitter Nuclear Medicine


Figure 22: Global Alpha Emitter Nuclear Medicine Market


32

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Figure 23: Global Brachytherapy Nuclear Medicine


• .


Global Brachytherapy Nuclear Medicine Devices Market

Figure 24: Global Brachytherapy Nuclear Medicine Market


33

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Figure 27: Global SPECT Nuclear Medicine Market Size,

By Value,2013-2017(USD Million)


Global SPECT Nuclear Medicine Market

Figure 28: Global SPECT Nuclear Medicine Market Size,

By Value,2018E-2023F (USD Million)

34

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Figure 29: Global PET Nuclear Medicine Market Size, By

Value, 2013-2017(USD Million)

• .


Global PET Nuclear Medicine Market

Figure 30: Global PET Nuclear Medicine Market Size, By

Value, 2018E-2023F (USD Million)

35

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Global Nuclear Medicine Market- By Indication


Indication, 2017 (%)

xx

Oncological Disorder

CardiovascularDisorder

Neurological Disorder

Others


Key Drivers

xx

xx

36

Global Nuclear Medicine Market- By Indication


Indication, 2023 (%)

xx


37

Oncological Disorder

CardiovascularDisorder

Neurological Disorder

Others

Key Drivers

xx

xx

• .


Global Nuclear Medicine For Oncological Disorders Market

Figure 33: Global Nuclear Medicine For Oncological

Disorders Market Size, By Value,2013-2017(USD Million)

Figure 34: Global Nuclear Medicine For Oncological

Disorders Market Size, By Value,2018E-2023F (USD Million)

38

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Figure 37: Global Nuclear Medicine For Cardiovascular

Disorders Market Size, By Value, 2013-2017(USD Million)

• .

Global Nuclear Medicine For Cardiovascular Disorders Market

Figure 38: Global Nuclear Medicine For Cardiovascular

Disorders Market Size, By Value, 2018E-2023F (USD Million)


39

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

40

Global Nuclear Medicine For Cardiovascular Disorders Market

Cardiomyopathy AndMyocarditis

Rheumatic Heart Disease

Ischemic Heart Disease

Stroke

Hypertensive Heart Disease

Atrial Fibrillation and Flutter

Peripheral Artery Disease

Endocarditis

Others

Figure 39: Cardiovascular Disease Prevalence, By Type ,2016

Source: IHME

40

• .


Global Nuclear Medicine For Neurological Disorders Market

Figure 41: Global Nuclear Medicine For Neurological

Disorders Market Size, By Value,2013-2017(USD Million)

Figure 42: Global Nuclear Medicine For Neurological

Disorders Market Size, By Value,2018E-2023F (USD Million)

41

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Figure 43: Global Nuclear Medicine For Others Disorders


• .


Global Nuclear Medicine For Other Disorders Market

Figure 44: Global Nuclear Medicine For Others Disorders

Market Size, By Value,2018E-2023F (USD Million)

42

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

North America Nuclear Medicine Market Overview


Figure 47: North America Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)

Increasing prevalence of various chronic disorders has been backing the growth of market.

43

Xx

Xx

Xx

Xx

Xx

Xx

Xx

2013 2014 2015 2016 2017

CAGR 2013-2017

xx%


Figure 49: North America Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )

Surging penetration of government health schemes coupled with increasing number of nuclear

centres is foreseen to support the market for nuclear medicine.

North America Nuclear Medicine Market Overview

44

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx

2018 2019 2020 2021 2022 2023

CAGR 2018-2023

xx%


Figure 50: North America Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)

CAGR 2013-2017

Diagnostic: xx%

Therapeutic: xx%

North America Nuclear Medicine Market, By Product

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Diagnostic 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Therapeutic 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

CAGR 2013-2017

Diagnostic: xx%

Therapeutic: xx%

Xx

Xx

Xx

Xx

Xx

Xx

45


Figure 51: North America Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)

CAGR 2013-2017

SPECT: xx%

PET: xx%

North America Nuclear Medicine Market, By Diagnostic Type

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

SPECT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

PET 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

CAGR 2013-2017

SPECT: xx%

PET: xx%

Xx

Xx

Xx

Xx

Xx

46


Figure 52: North America Nuclear Medicine Market : By Therapeutic Type , By Value, 2013-2023 (USD Million)

CAGR 2013-2017

Alpha Emitters: xx%

Beta Emitters: xx%

Brachytherapy: xx%

North America Nuclear Medicine Market, By Therapeutic Type

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Alpha Emitters 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Beta Emitters 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Brachytherapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

CAGR 2013-2017

Alpha Emitters: xx%

Beta Emitters: xx%

Brachytherapy: xx%

Xx

Xx

Xx

Xx

47


Figure 53: North America Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)

CAGR 2013-2017

Oncological Disorders: xx%;

Cardiovascular Disorders: xx%;

Neurological Disorders: xx%

Others: xx%

North America Nuclear Medicine Market, By Indication

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Oncological Disorders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Cardiovascular Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Neurological Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

CAGR 2018-2023




Others: xx%

48

• .


United States Nuclear Medicine Market Overview

Figure 59: United States Nuclear Medicine Market

Size, By Value, 2013-2017 (USD Million)

Figure 60: United States Nuclear Medicine Market

Size, By Value, 2018E-2023F (USD Million)

49

CAGR 2013-2017

xx%

CAGR 2018-2023

xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Xx

Xx

Xx

Xx

Xx

Xx

Xx

Xx


Figure 62: United States Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)

United States Nuclear Medicine Market – Analysis By Indication

50

CAGR 2013-2017




Others: xx%

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

Oncological Disorders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Cardiovascular Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Neurological Disoreders 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Others 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

CAGR 2018-2023




Others: xx%

About Azoth Analytics Pvt Ltd.

Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research

solutions and consulting services. An ISO 9001:2015 certified company, Azoth Analytics adheres to international quality management standard and has strong

commitment to a culture of continuous improvement. The business research and market analysis of Azoth Analytics helps organizations across different

industry verticals solve their business problems. Strategic market sizing and data dredging techniques include secondary research, and primary research

(interviews with management personnel and industry experts). Azoth Analytics provide syndicated and customized market research reports on different

verticals including pharmaceutical and healthcare, oil and gas and power, chemicals, automotive, technology, FMCG, food & beverages and media sectors.

Recent Azoth Analytics Reports

• Global Advanced Wound Care Market: Analysis By Type (Advanced Wound Dressings, Wound Therapy Devices, Wound Biologics), By

Application (Chronic Wounds, Acute Wounds), By End-User, By Region, By Country (2018 Edition): Opportunities and Forecasts (2018-

2023)

• Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition):

Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs,

Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)

• Global Transdermal Drug Delivery System Market: Analysis By Type (Patches, Gels), By Technique (Ionophoresis, Electroporation,

Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition): Trends, Opportunities and Forecast (2013-2023)

51

Global Nuclear Medicine Market: Analysis By Product Type ... · 7.4 Global Brachytherapy Nuclear...

Documents

Transcript of Global Nuclear Medicine Market: Analysis By Product Type ... · 7.4 Global Brachytherapy Nuclear...